Simultaneous capture and in situ analysis of circulating tumor cells using multiple hybrid nanoparticles

Biosensors and Bioelectronics

Volumn 47, Issue , 2013, Pages 508-514

  Lee, Hun Joo ^a,b   Cho, Hyeon Yeol ^b   Oh, Jin Ho ^a   Namkoong, Kak ^a   Lee, Jeong Gun ^a   Park, Jong Myeon ^a,c   Lee, Soo Suk ^a   Huh, Nam ^a   Choi, Jeong Woo ^b  

^a SAMSUNG Electronics   (South Korea)

^b Sogang University   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

Cell capture; Circulating tumor cell (CTC); In situ analysis; Micro pillar chip; Nanoparticle

Indexed keywords

CELL CAPTURE; CIRCULATING TUMOR CELLS; FLUORESCENCE SIGNALS; HYBRID NANOPARTICLE; IDENTIFICATION ACCURACY; IN-SITU ANALYSIS; MICRO PILLARS; SIMULTANEOUS CAPTURES;

FLUORESCENCE; PROTEINS;

NANOPARTICLES;

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITHELIAL CELL ADHESION MOLECULE; HYBRID NANOPARTICLE; NANOPARTICLE; QUANTUM DOT; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL COUNT; CELL PROLIFERATION; CELL VIABILITY; CIRCULATING TUMOR CELL; DNA CLEAVAGE; HUMAN; IN VITRO STUDY; PHENOTYPE; PROTEIN EXPRESSION;

ANTIBODIES; ANTIGENS, NEOPLASM; BIOTIN; BREAST NEOPLASMS; CELL ADHESION MOLECULES; DNA; FEMALE; FLUORESCENCE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; NANOPARTICLES; NEOPLASTIC CELLS, CIRCULATING; QUANTUM DOTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL;

EID: 84877082424     PISSN: 09565663     EISSN: 18734235     Source Type: Journal    
DOI: 10.1016/j.bios.2013.03.040     Document Type: Article

References (25)

1. Bednarz-Knoll N., et al. Breast Cancer Research 2011, 13(6):228.
2. Chung Y.K., et al. Biosensors and Bioelectronics 2011, 26(5):2520-2526.
3. Cohen S.J., et al. Journal of Clinical Oncology 2008, 26(19):3213-3221.
4. Gerges N., Rak J., Jabado N. British Medical Bulletin 2010, 94:49-64.
5. Goldhirsch A., et al. Annals of Oncology 2011, 22(8):1736-1747.
6. Gorges T.M., et al. BMC Cancer 2012, 12:178.
7. Ignatiadis M., Reinholz M. Breast Cancer Research 2011, 13(5):222.
8. Kirby B.J., et al. PLoS One 2012, 7(4):e35976.
9. Kumeria T., et al. Biosensors and Bioelectronics 2012, 35(1):167-173.
10. Lazar D.C., et al. Physical Biology 2012, 9(1):016002.
11. Lee H.J., et al. Biosensors and Bioelectronics 2009, 24(10):3120-3125.
12. Lin C.W., et al. Journal of Biological Chemistry 2012, 287(47):39449-39459.
13. Lin H., et al. Critical Reviews in Oncology/Hematology 2011, 77(1):1-11.
14. Nagrath S., et al. Nature 2007, 450(7173):1235-1239.
15. Pantel K., Alix-Panabières C. Trends in Molecular Medicine 2010, 16(9):398-406.
16. Paterlini-Brechot P., Benali N.L. Cancer Letters 2007, 253(2):180-204.
17. Peng J., Jordan V.C. International Journal of Oncology 2010, 36(2):451-458.
18. Prang N., et al. British Journal of Cancer 2005, 92(2):342-349.
19. Punnoose E.A., et al. PLoS One 2010, 5(9):e12517.
20. Riethdorf S., et al. Clinical Cancer Research 2010, 16(9):2634-2645.
21. Sieuwerts A.M., et al. Journal of the National Cancer Institute 2009, 101(1):61-66.
22. Sihto H., et al. Breast Cancer Research 2011, 13(5):R87.
23. Talasaz A.H., et al. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(10):3970-3975.
24. Yu M., et al. Journal of Cell Biology 2011, 192(3):373-382.
25. Zylstra, J., et al., 2012. Tailoring quantum dot interfaces for improved biofunctionality and energy transfer, In: Hepel, M., Zhong, C.J. (Eds.), Functional Nanoparticles for Bioanalysis, Nanomedicine and Bioelectronic Devices, vol. 1, ACS Symposium Series, vol. 1112, Oxford University Press, Oxford, pp. 212-245.